Search Within

Stephen Stacy Roberts

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (13)
Groups
  1. Epidemiology and Biostatistics (30)
  2. Neuroblastoma Service (30)
  3. Pediatrics, Department of (30)
  4. Tow Center for Developmental Oncology (TCDO) (27)
  5. GSK Faculty (25)
  6. Sloan Kettering Institute Postdocs (25)

More Groups

People
  1. Shakeel Modak (22)
  2. Audrey Mauguen (18)
  3. Brian Kushner (18)
  4. Ellen Basu (18)
  5. Nai-Kong Cheung (18)
  6. Irene Cheung (10)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (4)
  6. 2019 (7)

More Years

Publications
  1. Pediatric Blood and Cancer (10)
  2. Cancer Research (3)
  3. Journal of Clinical Oncology (3)
  4. Cancer (1)
  5. Cancer Discovery (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (10)
  2. American Association for Cancer Research (6)
  3. American Society of Clinical Oncology (4)
  4. Nature Publishing Group (2)
  5. American Academy of Pediatrics (1)
  6. American Medical Association (1)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • TPX-0005 (Repotrectinib), a next-generation ALK/ROS1/NTRK1-3 inhibitor, has potent antiproliferative and anti-tumor activity as monotherapy and in combination with chemotherapy in neuroblastoma cell lines and pediatric patient derived xenograft models
    Meeting Abstract

    O'Donohue, T.; Ibáñez, G.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; Roberts, S.; Dela Cruz, F.; Kung, A.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Prospective agnostic germline testing in pediatric cancer patients
    Meeting Abstract

    Fiala, E.; Kennedy, J.; Kemel, Y.; Mauguen, A.; Mandelker, D.; Zehir, A.; Birsoy, O.; Bouvier, N.; Maio, A.; Latham, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save